|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2011-8-23
|
|
pubmed:abstractText |
Some (but not all) prior trials have reported differential outcomes after percutaneous coronary intervention with paclitaxel-eluting stents versus stents eluting rapamycin analogs according to the presence of diabetes mellitus. These studies lacked sufficient power to examine individual safety and efficacy end points.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
23
|
|
pubmed:volume |
124
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
893-900
|
|
pubmed:meshHeading |
pubmed-meshheading:21824922-Angioplasty, Balloon, Coronary,
pubmed-meshheading:21824922-Coronary Artery Disease,
pubmed-meshheading:21824922-Diabetic Angiopathies,
pubmed-meshheading:21824922-Drug-Eluting Stents,
pubmed-meshheading:21824922-Humans,
pubmed-meshheading:21824922-Immunosuppressive Agents,
pubmed-meshheading:21824922-Paclitaxel,
pubmed-meshheading:21824922-Randomized Controlled Trials as Topic,
pubmed-meshheading:21824922-Sirolimus,
pubmed-meshheading:21824922-Tubulin Modulators
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.
|
|
pubmed:affiliation |
New York–Presbyterian Hospital, Columbia University Medical Center, The Cardiovascular Research Foundation, New York, NY 10022, USA. gs2184@columbia.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
